Inovia Capital led a $15.5m in Series A round in Medeloop.

Inovia Capital, a private equity firm, led a $15.5m in Series A round in Medeloop, a pioneering medical research platform, with participation from Inovia Capital, Icon Ventures, General Catalyst, Maven Ventures, Healthier Capital, Up2 Opportunity Fund, and CFO Advisors. "I founded Medeloop driven by the personal mission of finding a cure for my daughter’s Complex Regional Pain Syndrome (CRPS)—a condition still eluding effective treatment. This experience revealed the inefficiencies in current medical research and the critical need for innovative solutions. Supported by leading investors like Inovia Capital and Icon Ventures, we've crafted a platform that accelerates research, reduces costs, and enables significant advancements in patient outcomes. Our goal is to revolutionize healthcare research, delivering profound impacts where they are desperately needed," Rene Caissie, Medeloop CEO.